European Expansion: The Partnering Question
Executive Summary
Executives from three biotechnology companies--Biogen, Gilead and Pharmion-told attendees at Windhover's 2d annual Marketing Pharmaceutical Innovation conference how the stark partnering/go-it-alone choices biotechs used to face (launch on your own, with a multinational, or in a network of local drug firms) are becoming far more nuanced as the partnering infrastructure available to the newer generation of start-ups expands to meet the broader opportunities.